US EditionFirst Japanese Pharma Giant Astellas Opens Research Hub for Korean Biotech Startups
SEOUL, SOUTH KOREA, JUL 17 – The partnership aims to boost Korean drug-discovery startups' growth by providing lab space, expert consultations, and funding, supporting global expansion, KISED said.
- On July 17, 2025, Astellas Pharma Inc. agreed an MoU with KISED to operate the Partnership with Global Companies Program.
- The Partnership with Global Companies Program is designed to identify Korean drug-discovery startups and offer support by providing lab and office space, expert consultations, and funding.
- Two startups—TCUBEiT Inc. and AAVATAR Therapeutics—were selected, and they will begin collaboration at SakuLabTM-Tsukuba.
- Called `very pleased to agree on a MoU with KISED`, Tadaaki Taniguchi said.
- With collaboration imminent, KISED plans to expand its global support networks, while financial impact on Astellas is expected to be minor.
Insights by Ground AI
Does this summary seem wrong?
69 Articles
69 Articles
Rutland Herald+67 Reposted by 67 other sources
Astellas Announces a Partnership with the "Korea Institute of Startup and Entrepreneurship Development", an Umbrella Organization of the "Ministry of SMEs and Startups", a Korean Government Agency, for the Operation of the "Partnership with Global Compani
Supporting Korean Startups' Drug Discovery Research and Global Expansion
Coverage Details
Total News Sources69
Leaning Left5Leaning Right6Center26Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
14%
C 70%
R 16%
Factuality
To view factuality data please Upgrade to Premium
